{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:05:48Z","timestamp":1792785948619,"version":"4.5.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"China Antimicrobial Surveillance Network"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["2023QD020"],"award-info":[{"award-number":["2023QD020"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Antimicrobial Surveillance Network","award":["3030231003"],"award-info":[{"award-number":["3030231003"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To monitor the trends of carbapenem-resistant gram-negative bacteria to antimicrobial agents in healthcare facilities in major regions of China between 2015 and 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Carbapenem-resistant gram-negative isolates from 74 hospitals in the country were tested for antimicrobial susceptibility using an automated method (imported or domestic AST instruments) supplemented by the disc diffusion method. Results were evaluated using the 2024 CLSI breakpoint.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 339 513 clinical isolates were collected between 2015 and 2024. Among clinical Enterobacterales isolates, the rate of carbapenem resistance was generally below 13%, except for Klebsiella spp., where it ranged from 20.4% to 21.9%. Most clinical Enterobacterales isolates are highly susceptible to tigecycline, colistin, and polymyxin B, with resistance rates ranging from 0.1% to 15.4%. The detection rate of meropenem-resistant Pseudomonas aeruginosa has decreased over six consecutive years, from 31.4% in 2018 to 21.5% in 2024. The detection rate of meropenem-resistant Acinetobacter baumannii remained modest, from 64.9% in 2015 to 68.3% in 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Multidrug-resistant bacteria remain a significant challenge in clinical anti-infective treatment, and the surveillance of bacterial resistance and the rational use of antimicrobial agents need to be further strengthened to combat bacterial resistance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/infdis\/jiag083","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T12:48:23Z","timestamp":1770209303000},"page":"S113-S117","source":"Crossref","is-referenced-by-count":2,"title":["Trends of Carbapenem-Resistant Gram-negative Bacteria in China: A Surveillance Study Between 2015 and 2024"],"prefix":"10.1093","volume":"233","author":[{"given":"Yan","family":"Guo","sequence":"first","affiliation":[{"name":"Institute of Antibiotics, Huashan Hospital, Fudan University , Shanghai ,","place":["China"]},{"name":"Key Laboratory of Clinical Pharmacology of Antibiotics, Ministry of Health , Shanghai ,","place":["China"]},{"name":"Joint Laboratory of Hospital & Enterprise for Pathogen Diagnosis of Drug-Resistant Bacterial Infections and Innovative Drug R&D , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1436-3668","authenticated-orcid":false,"given":"Li","family":"Ding","sequence":"additional","affiliation":[{"name":"Institute of Antibiotics, Huashan Hospital, Fudan University , Shanghai ,","place":["China"]},{"name":"Key Laboratory of Clinical Pharmacology of Antibiotics, Ministry of Health , Shanghai ,","place":["China"]},{"name":"Joint Laboratory of Hospital & Enterprise for Pathogen Diagnosis of Drug-Resistant Bacterial Infections and Innovative Drug R&D , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhao","family":"Zhou","sequence":"additional","affiliation":[{"name":"Institute of Antibiotics, Huashan Hospital, Fudan University , Shanghai ,","place":["China"]},{"name":"Key Laboratory of Clinical Pharmacology of Antibiotics, Ministry of Health , Shanghai ,","place":["China"]},{"name":"Joint Laboratory of Hospital & Enterprise for Pathogen Diagnosis of Drug-Resistant Bacterial Infections and Innovative Drug R&D , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Ren","sequence":"additional","affiliation":[{"name":"Institute of Antibiotics, Huashan Hospital, Fudan University , Shanghai ,","place":["China"]},{"name":"Key Laboratory of Clinical Pharmacology of Antibiotics, Ministry of Health , Shanghai ,","place":["China"]},{"name":"Medical Laboratory, Tengchong People's Hospital , Yunnan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renru","family":"Han","sequence":"additional","affiliation":[{"name":"Institute of Antibiotics, Huashan Hospital, Fudan University , Shanghai ,","place":["China"]},{"name":"Key Laboratory of Clinical Pharmacology of Antibiotics, Ministry of Health , Shanghai ,","place":["China"]},{"name":"Joint Laboratory of Hospital & Enterprise for Pathogen Diagnosis of Drug-Resistant Bacterial Infections and Innovative Drug R&D , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Yin","sequence":"additional","affiliation":[{"name":"Institute of Antibiotics, Huashan Hospital, Fudan University , Shanghai ,","place":["China"]},{"name":"Key Laboratory of Clinical Pharmacology of Antibiotics, Ministry of Health , Shanghai ,","place":["China"]},{"name":"Joint Laboratory of Hospital & Enterprise for Pathogen Diagnosis of Drug-Resistant Bacterial Infections and Innovative Drug R&D , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Wu","sequence":"additional","affiliation":[{"name":"Institute of Antibiotics, Huashan Hospital, Fudan University , Shanghai ,","place":["China"]},{"name":"Key Laboratory of Clinical Pharmacology of Antibiotics, Ministry of Health , Shanghai ,","place":["China"]},{"name":"Joint Laboratory of Hospital & Enterprise for Pathogen Diagnosis of Drug-Resistant Bacterial Infections and Innovative Drug R&D , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[{"name":"Institute of Antibiotics, Huashan Hospital, Fudan University , Shanghai ,","place":["China"]},{"name":"Key Laboratory of Clinical Pharmacology of Antibiotics, Ministry of Health , Shanghai ,","place":["China"]},{"name":"Joint Laboratory of Hospital & Enterprise for Pathogen Diagnosis of Drug-Resistant Bacterial Infections and Innovative Drug R&D , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siquan","family":"Shen","sequence":"additional","affiliation":[{"name":"Institute of Antibiotics, Huashan Hospital, Fudan University , Shanghai ,","place":["China"]},{"name":"Key Laboratory of Clinical Pharmacology of Antibiotics, Ministry of Health , Shanghai ,","place":["China"]},{"name":"Joint Laboratory of Hospital & Enterprise for Pathogen Diagnosis of Drug-Resistant Bacterial Infections and Innovative Drug R&D , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demei","family":"Zhu","sequence":"additional","affiliation":[{"name":"Institute of Antibiotics, Huashan Hospital, Fudan University , Shanghai ,","place":["China"]},{"name":"Key Laboratory of Clinical Pharmacology of Antibiotics, Ministry of Health , Shanghai ,","place":["China"]},{"name":"Joint Laboratory of Hospital & Enterprise for Pathogen Diagnosis of Drug-Resistant Bacterial Infections and Innovative Drug R&D , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fupin","family":"Hu","sequence":"additional","affiliation":[{"name":"Institute of Antibiotics, Huashan Hospital, Fudan University , Shanghai ,","place":["China"]},{"name":"Key Laboratory of Clinical Pharmacology of Antibiotics, Ministry of Health , Shanghai ,","place":["China"]},{"name":"Joint Laboratory of Hospital & Enterprise for Pathogen Diagnosis of Drug-Resistant Bacterial Infections and Innovative Drug R&D , Shanghai ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"2026031706364372300_jiag083-B1","volume-title":"CLSI Guideline M100","author":"CLSI","year":"2024","edition":"34th ed"},{"key":"2026031706364372300_jiag083-B2"},{"key":"2026031706364372300_jiag083-B3","doi-asserted-by":"crossref","first-page":"136374","DOI":"10.1016\/j.jhazmat.2024.136374","article-title":"Epidemiological and genomic analysis revealed the significant role of flies in dissemination of carbapenem-resistant Enterobacteriaceae (CRE) in China","volume":"480","author":"Zhou","year":"2024","journal-title":"J Hazard Mater"},{"key":"2026031706364372300_jiag083-B4","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1080\/22221751.2020.1799721","article-title":"Prevalence, risk factors and molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in patients from Zhejiang, China, 2008\u20132018","volume":"9","author":"Hu","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"2026031706364372300_jiag083-B5","first-page":"881","article-title":"Clinical features and molecular epidemiology of carbapenem-resistant Enterobacterales infection in children","volume":"24","author":"Ye","year":"2022","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"2026031706364372300_jiag083-B6","first-page":"907","article-title":"Antimicrobial resistance changes of carbapenem-resistant Enterobacteriaceae strains isolated from children","volume":"56","author":"Guo","year":"2018","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"2026031706364372300_jiag083-B7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jgar.2024.03.020","article-title":"Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018\u20132022","volume":"37","author":"Wise","year":"2024","journal-title":"J Glob Antimicrob Resist"},{"key":"2026031706364372300_jiag083-B8","doi-asserted-by":"crossref","first-page":"ofaf005","DOI":"10.1093\/ofid\/ofaf005","article-title":"Frequency, antimicrobial susceptibility, and molecular characterization of carbapenem-resistant Enterobacterales stratified by United States census divisions: results from the INFORM program (2018\u20132022)","volume":"12","author":"Sader","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"2026031706364372300_jiag083-B9","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/S2666-5247(22)00329-9","article-title":"Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study","volume":"4","author":"Reyes","year":"2023","journal-title":"Lancet Microbe"},{"key":"2026031706364372300_jiag083-B10","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fcimb.2020.00314","article-title":"China Antimicrobial Surveillance Network (CHINET) Study Group. Dissemination of carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) among carbapenem-resistant Enterobacteriaceae isolated from adult and children patients in China","volume":"10","author":"Han","year":"2020","journal-title":"Front Cell Infect Microbiol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/233\/Supplement_1\/S113\/67341065\/jiag083.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/233\/Supplement_1\/S113\/67341065\/jiag083.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T10:36:50Z","timestamp":1773743810000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/233\/Supplement_1\/S113\/8519480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":10,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2026,3,10]]},"published-print":{"date-parts":[[2026,3,13]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiag083","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3,15]]},"published":{"date-parts":[[2026,3,10]]}}}